LFST250417P11000
- 3.80
- 0.000.00%
LifeStance Health Newsroom
CCORF Initiates LifeStance Health(LFST.US) With Buy Rating, Announces Target Price $8
This Talkspace Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Express News | Canaccord Genuity Initiates Coverage On LifeStance Health Gr With Buy Rating, Announces Price Target of $8
LifeStance Health Gr Analyst Ratings
When Will LifeStance Health Group, Inc. (NASDAQ:LFST) Become Profitable?
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Insider Sale: See Remarks of $LFST Sells 18,845 Shares
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
J.P. Morgan Maintains LifeStance Health(LFST.US) With Hold Rating, Raises Target Price to $8
Is Now The Time To Look At Buying LifeStance Health Group, Inc. (NASDAQ:LFST)?
Lifestance Health Group Insider Sold Shares Worth $264,293, According to a Recent SEC Filing
LifeStance Health's Earnings Call Highlights Strong Growth
UBS Adjusts Price Target on Lifestance Health Group to $8.50 From $7.50, Maintains Neutral Rating
Hospital Stocks Fall Amid Medicaid Funding Concerns
Earnings Call Summary | LifeStance Health(LFST.US) Q4 2024 Earnings Conference
Goldman Sachs Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $11
Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10
Analysts Conflicted on These Healthcare Names: Ligand Pharma (LGND), GoodRx Holdings (GDRX) and Lifestance Health Group (LFST)
Is Now An Opportune Moment To Examine LifeStance Health Group, Inc. (NASDAQ:LFST)?